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Abstract
TLR signaling is a crucial component of the innate immune response to infection. MicroRNAs (miRNAs) have been shown to
be upregulated during TLR signaling. Specifically, microRNA-146a (miR-146a) plays a key role in endotoxin tolerance by
downregulating interleukin-1 receptor-associated kinase 1 (IRAK-1). The aim of this study was to assess the role of miR-146a
in the TLR2 signaling and development of bacterial lipoprotein (BLP) self-tolerance and cross-tolerance to bacteria.
Expression of miR-146a increased in a dose- and time-dependent manner in BLP-stimulated human THP-1 promonocytic
cells. In BLP-tolerised cells miR-146a was even further upregulated in response to BLP re-stimulation (p,0.001). Re-
stimulation of BLP-tolerised cells with heat-killed gram-negative Salmonella typhimurium (S. typhimurium), but not gram-
positive Staphylococcus aureus (S. aureus), led to significant overexpression of miR-146a (p,0.05). Transfection of naive cells
with a miR-146a mimic substantially suppressed TNF-a production (p,0.05). Furthermore, overexpression of miR-146a
resulted in strong reduction in IRAK-1 and phosphorylated IkBa expression in naive and S. typhimurium-stimulated THP-1
cells. Collectively, miR-146a is upregulated in response to BLP and bacterial stimulation in both naive and BLP-tolerised cells.
Overexpression of miR-146a induces a state analogous to tolerance in BLP-stimulated cells and therefore may represent
a future target for exogenous modulation of tolerance during microbial infection and sepsis.
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Introduction
Sepsis is the leading cause of death in patients who are critically
ill [1] and the annual incidence of sepsis continues to increase [2].
Sepsis is the systemic inflammatory response to infection and the
initial host response to infection is mediated via activation of the
innate immune system [3]. The cells of the innate immune system
express pattern recognition receptors (PRRs), such as Toll-like
receptors (TLRs) which recognize and transduce signals on contact
with bacterial components [3]. The immune response is initiated
following recognition of these structural components of bacteria,
called pathogen-associated molecular patterns (PAMPs), such as
lipopolysaccharide (LPS) or endotoxin in gram-negative bacteria
and peptidoglycan (PGN) in gram-positive bacteria [4]. There are
10 functional TLRs in humans and each has a distinct function in
terms of PAMP recognition and immune responses [5]. TLR2
responds to PGN, lipoteichoic acid (LTA) and bacterial lipopro-
tein (BLP), whereas TLR4 responds to LPS [5,6]. TLR2 signals
via the myeloid differentiation factor 88 (MyD88)-dependent
signaling pathway [7].
Pre-exposure of monocytes/macrophages (in vitro) or the host
(in vivo) to LPS or endotoxin induces a transient state of cellular
hyporesponsiveness to a secondary LPS challenge with diminished
production of proinflammatory cytokines, thereby conferring
protection against LPS-induced lethality and resulting in a signif-
icant survival advantage [8–10]. This phenomenon is well
established and termed endotoxin tolerance. Furthermore, emerg-
ing evidence has revealed that modulation of the TLR4-mediated
signal transduction pathway is involved in the development of
endotoxin tolerance [9,10]. For example, down-regulated cell-
surface expression of TLR4, reduced interleukin-1 receptor-
associated kinase 1 (IRAK-1) expression and myeloid differenti-
ation factor 88 (MyD88)-IRAK immunocomplex formation, and
attenuated nuclear factor (NF)-kB activation and mitogen-
activated protein kinase (MAPK) phosphorylation are all consid-
ered as significant markers for endotoxin tolerance. Therefore,
endotoxin tolerance may represent a protective mechanism, whose
primary function is to prevent excessive inflammatory response
induced by overactivation of the TLR4 signaling pathway. It has
been shown that endotoxin tolerance occurs in several disease
settings including sepsis, trauma, surgery and pancreatitis [9];
however, acquisition of endotoxin tolerance may contribute to an
increased incidence of secondary bacterial infection in hospitalized
patients due to development of an immunesuppressed state [9,10].
Tolerance to components of gram-positive bacterial cell wall
such as BLP and LTA also occurs [11], although this has been
a lesser studied phenomenon [12]. BLP tolerance is associated
with a reduction in levels of tumor necrosis factor-a (TNF-a) and
interleukin (IL)-6 after subsequent BLP stimulus [11], via
suppressed NF-kB activation [13]. Cross-tolerance of endotoxin-
primed cells to other TLR ligands has also been described [14],
following endotoxin exposure cells are hyporesponsive to stimu-
lation with other TLR ligands as well as hyporesponsive to further
endotoxin stimulation. The clinical significance of tolerance
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development and potential exogenous modulation of tolerance in
human sepsis is as yet undetermined.
MicroRNAs (miRNAs) are a class of evolutionarily conserved
small RNA [15], the first discovered members of which were lin-4
and let-7 [16–18]. Since then hundreds of miRNAs have been
identified in plants, animals and viruses [19], with more than 700
miRNA genes identified in the human genome [20]. miRNAs bind
to the 39 untranslated (UTR) region of target messenger RNA to
downregulate gene expression [16–18]. miRNAs are transcribed
by RNA polymerase II or RNA polymerase III to generate a stem-
loop, containing primary miRNA [19]. This primary miRNA is
processed by the RNase III enzyme, Drosha, to produce precursor
miRNA, which is then cleaved to produce the mature miRNA by
another RNase III enzyme, Dicer [19]. The miRNA is in-
corporated into the RNA-induced silencing complex (RISC) and
guides the RISC to its RNA targets by base-pairing interactions
[19]. miRNAs regulate target mRNA at the posttranscriptional
level either by mRNA degradation or translational repression
[21,22].
miRNAs have been found to have diverse roles, including roles
in immune responses [15,23–25]. Taganov et al. [15] first
demonstrated that the human miRNAs miR-146a/b, miR-132
and miR-155 are upregulated in response to LPS stimulation of
the human promonocyte THP-1 cell line. Nahid et al. [23]
subsequently confirmed miR-146a upregulation in response to
LPS in THP-1 cells, additionally showing that levels of miR-146a
continue to rise with ongoing exposure to LPS beyond 24 h and
that miR-146a expression is LPS dose-dependent. Nahid et al.
[23] further went on to describe a role for miR-146a in endotoxin
tolerance development via negative feedback on tumor necrosis
factor receptor-activated factor 6 (TRAF6) and IRAK-1. A similar
response has been seen in miR-146a-transfected cells exposed to
subsequent stimulation with BLP [26].
The aim of this study was to examine the putative role of miR-
146a as a contributor to the development of BLP tolerance and to
further assess for a role for miR-146a in BLP cross-tolerance to
both gram-positive and gram-negative bacteria. We report here
that miR-146a is upregulated in response to either BLP or
bacterial stimulation in both naive and BLP-tolerised human
THP-1 cells and that miR-146a negatively regulates the TLR2
signaling pathway in BLP-induced self-tolerance and cross-
tolerance to gram-negative bacteria.
Materials and Methods
Reagents
RPMI-1640 supplemented with 10% heat-inactivated fetal calf
serum (FCS), penicillin (100 units/ml), streptomycin sulphate
(100 mg/ml) and glutamine (2 mM) was used as the cell culture
medium for all experiments except transfection experiments where
RPMI-1640 without added FCS and antibiotics was used. All
medium and reagents used for cell cultures were purchased from
Invitrogen Life Technologies (Paisley, Scotland, U.K.). Synthetic
bacterial lipoprotein (Pam3-Cys-Ser-Lys4-OH) that was endotox-
in-free as confirmed by the Limulus amebocyte lysate assay
(Charles River Endosafe, Charleston, SC) was obtained from
EMC Microcollections (Tubingen, Germany) and reconstituted to
the necessary concentrations using sterile phosphate buffered
saline (PBS) (Invitrogen Life Technologies).
Cell Cultures and Induction of Tolerance
The undifferentiated human promonocytic THP-1 cell line
obtained from the American Type Culture Collection (ATCC,
Manassas, VA) was cultured in complete RPMI 1640 at 37uC in
humidified 5% CO2. For tolerance experiments, cells at a density
of 16106 or 56105 cells/ml were plated in 24-well plates (Falcon,
Lincoln Park, NJ) and incubated with 100 ng/ml BLP for 18 h to
induce tolerance as demonstrated previously [13,26,27] and then
washed twice with PBS prior to being stimulated with BLP or
heat-killed bacteria or left in culture medium alone as a control.
Dose-response effects were established by using different tolerising
doses of BLP; in these experiments cells were incubated with either
10, 100 or 1,000 ng/ml BLP for 18 h prior to re-stimulation.
Preparation of Heat-killed Bacteria
Gram-positive Staphylococcus aureus (S. aureus) and gram-negative
Salmonella typhimurium (S. typhimurium) were obtained from ATCC
and the National University of Ireland Culture Collection,
respectively. Bacteria were cultured at 37uC in trypticase soy
broth (Merck, Darmstadt, Germany), harvested at the midloga-
rithmic growth phase, washed twice and resuspended in PBS. The
concentration of resuspended bacteria was determined and
adjusted spectrophotometrically at 550 nm. Different concentra-
tions were made at 26107 CFU/ml for S. aureus and 26106 CFU/
ml for S. typhimurium. Aliquots of 1 ml of each were heat-killed at
95uC for 20 min before being used immediately or stored at -80uC
until further use.
RNA Extraction, Reverse Transcription and Real-time PCR
RNA was extracted from THP-1 cells using the miRNeasy Mini
Kit (Qiagen, Crawley, U.K.) as per manufacturer’s instructions.
Extracted RNA was diluted to concentrations of 1 ng/ml using
nuclease-free water (Applied Biosystems, Carlsbad, CA). cDNA
synthesis was performed using the TaqMan MicroRNA Reverse
Transcriptase kit (Applied Biosystems) and specific primers from
TaqMan microRNA assays (Applied Biosystems) for miR-146a
using 5 ml (5 ng) of RNA for each reverse transcriptase reaction, as
per manufacturer’s instructions. Real-time quantitative PCR
(qRT-PCR) was performed using TaqMan microRNA assays
(Applied Biosystems) following the manufacturer’s protocol. miR-
146a expression levels were normalized to the stably expressed
endogenous small nucleolar RNA control RNU44 (Applied
Biosystems) as validated previously [23]. Expression levels of
miR-146a were calculated using the 22DDCt method [28].
Cell Transfection
Prior to transfection, 500 ml of THP-1 cells at 56105 cells/ml
were plated into each well of 24-well plates with serum- and
antibiotic-free RPMI-1640 culture medium, and incubated at
37uC with 5% CO2 for 12 h. Cells were transfected with 40 nM of
either miR-146a mimic or miRNA negative control (Ambion,
Carlsbad, CA) using 1 ml lipofectamine 2000 (Invitrogen Life
Technologies). Twelve hours after transfection, cells were further
stimulated with either complete culture medium, 1,000 ng/ml
BLP, 16106 CFU/ml S. typhimurium or 16107 CFU/ml S. aureus
for 6 h.
Measurement of TNF-a, IRAK-1 and Phosphorylated IkBa
TNF-a concentrations in cell-free supernatants from different
experiments were assessed by ELISA (eBioscience, Hatfield, U.K.)
as per manufacturer’s instructions.
Naive, BLP-tolerised and miR-146a mimic-transfected THP-1
cells were stimulated with 16106 CFU/ml S typhimurium for various
time periods, washed with ice-cold PBS and lysed on ice in cell
lysis buffer (Cell Signaling Technology, Beverly, MA) supplemen-
ted with 1 mM phenylmethylsulfonyl fluoride and protease
inhibitor cocktail (Roche, Indianapolis, IN). The resultant lysates
miR-146a and BLP Tolerance
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were centrifuged and supernatants containing the cytoplasmic
proteins were collected. Protein concentration was measured using
a micro bicinchoninic acid protein assay (Pierce, Rockford, IL).
Equal amounts of protein extracts were separated on a 10% SDS-
polyacrylamide gel and trans-blotted onto polyvinylidene difluor-
ide membranes (Schleicher & Schuell, Dassel, Germany).
Membranes were blocked for 1 h at room temperature with 5%
nonfat milk in 0.1% PBS/Tween-20 and probed overnight at 4˚C
with the appropriate primary Ab IRAK-1 (Cell Signaling
Technology) or phospho-IkBa (Cell Signaling Technology). Blots
were then incubated with the appropriate HRP-conjugated
secondary Ab (Dako, Cambridge, U.K.) at room temperature
for 1 h, developed with the enhanced chemiluminescence system
(Pierce) and captured with Scion image system (Scion Inc,
Frederick, MD).
Statistical Analysis
Data are expressed as mean 6 standard error of the mean.
Statistical analysis was performed using Student’s t test for
normally distributed data and Mann-Whitney-U test for non-
parametric data. Correlations between TNF-a and miR-146a in
response to BLP stimulation were assessed using the Pearson
correlation coefficient test. The p values ,0.05 were considered
statistically significant.
Results
miR-146a is Upregulated by Activation of the TLR2
Signaling
Human THP-1 cells were stimulated with variable doses of BLP
at 10, 100 and 1,000 ng/ml for 6, 12 and 24 h. Maximal TNF-
a levels were seen at 6 h with a fall in TNF-a levels at 24 h
(p,0.01 versus the TNF-a levels at 6 h) and this occurred in
a dose-dependent manner (Figure 1A). miR-146a expression was
also induced by BLP stimulation in a dose-dependent manner
(p,0.05 versus naive cells) (Figure 1B). Maximal miR-146a levels
were seen with 1,000 ng/ml BLP after a 24-h stimulation
(Figure 1C). As shown in Figure 1D, opposing responses were
seen from TNF-a and miR-146a in relation to prolonged
stimulation with BLP. Whilst TNF-a levels decreased with a longer
duration of BLP stimulation, miR-146a expression levels contin-
ued to rise after 24 h of BLP stimulation, indicating a strong
negative correlation between TNF-a levels and miR-146a
expression in response to BLP stimulation (r=20.967; p,0.001).
miR-146a Plays a Role in BLP Tolerance
Naive and BLP-tolerised THP-1 cells were re-stimulated with
1,000 ng/ml BLP for 6 h. As shown in Figure 2A, BLP-tolerised
cells showed a substantial reduction in TNF-a levels in response to
Figure 1. Activation of the TLR2 signaling upregulates miR-146a expression. (A) Human THP-1 cells were stimulated with various doses of
BLP for 6, 12 and 24 h. (B, C and D) THP-1 cells were stimulated with various doses of BLP for 24 h (B) or stimulated with 1,000 ng/ml BLP for various
time periods (C and D). THP-1 cells incubated with culture medium were used as the control. TNF-a concentrations in the culture supernatants were
assessed by ELISA, and miR-146a levels in THP-1 cells were detected by real-time PCR and expressed as fold expression. Data are presented as mean
6 SE of three independent experiments, and each experiment was conducted in triplicate. (A, B and C) *p,0.05, **p,0.01 compared with naive cells
or the 6-h levels of either TNF-a or miR-146a. (D) The r value was calculated using the Pearson correlation coefficient test.
doi:10.1371/journal.pone.0062232.g001
miR-146a and BLP Tolerance
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BLP re-stimulation compared with naive cells (p,0.01). By
contrast, miR-146a levels were significantly upregulated in BLP-
tolerised cells following BLP re-stimulation (p,0.05 versus naive
cells) (Figure 2B). Transfection of THP-1 cells with miR-146a
mimic resulted in significant overexpression of miR-146a when
compared to transfection with miRNA negative control
(Figure 2C), confirming successful transfection of miR-146a mimic
in THP-1 cells. Moreover, transfection of THP-1 cells with miR-
146a mimic led to significant suppression of TNF-a in response to
BLP stimulation compared with cells transfected with miRNA
negative control (p,0.05) (Figure 2D).
miR-146a Participates in BLP-induced Cross-tolerance to
Gram-negative Bacteria
Naive and BLP-tolerised THP-1 cells were re-stimulated with
either heat-killed S. typhimurium (16106 CFU/ml) or heat-killed S.
aureus (16107 CFU/ml) for 6 h. As demonstrated in Figure 3A, the
almost completely attenuated TNF-a release in the supernatants
confirmed BLP-induced cross-tolerance to both gram-negative
and gram-positive bacteria (p,0.01 versus naive cells). In BLP-
tolerised cells, subsequent stimulation with gram-negative S.
typhimurium caused significantly increased expression of miR-146a
(p,0.05 versus naive cells) (Figure 3B). However, this was not the
case in BLP-tolerised cells subsequently stimulated with gram-
positive S. aureus (Figure 3B).
Dose-dependent tolerisation was then examined by pre-treating
THP-1 cells with BLP at 10, 100 and 1,000 ng/ml for 18 h and
re-stimulating these cells with heat-killed S. typhimurium for a further
6 h. BLP-induced cross-tolerisation to S. typhimurium was shown to
be BLP dose-dependent, as confirmed by the attenuated TNF-
a release (Figure 3C). S. typhimurium-induced upregulation of miR-
146a expression in BLP-tolerised cells was also shown to be
dependent on the tolerising dose of BLP (Figure 3D).
Finally, we transfected THP-1 cells with miR-146a mimic or
miR negative control and re-stimulated these cells with either
heat-killed S. typhimurium (16106 CFU/ml) or heat-killed S. aureus
(16107 CFU/ml) for 6 h. In comparison to THP-1 cells
transfected with miR negative control, miR-146a mimic trans-
fection resulted in a significant attenuation in S. typhimurium
stimulation-induced TNF-a production (p,0.05) (Figure 3E). By
contrast, although transfection with miR-146a mimic led to
partially reduced TNF-a release from cells stimulated with S.
aureus, it did not reach a statistical significance (Figure 3F).
Both IRAK-1 and Phosphorylated IkBa are Inhibited in
miR-146a Mimic-transfected Cells
Both reduced IRAK-1 protein expression and inhibited IkBa
phosphorylation have been shown to be associated with BLP-
induced tolerance [27]. Therefore, we assessed IRAK-1 and
phosphorylated IkBa expression in naive, BLP-tolerised and miR-
146a mimic-transfected THP-1 cells stimulated with heat-killed S.
typhimurium (16106 CFU/ml) for various time periods. Stimulation
of naive THP-1 cells with S. typhimurium led to a relatively reduced
IRAK-1 expression (Figure 4A and 4C) and markedly enhanced
IkBa phosphorylation 30 min post stimulation (Figure 4B and
4D), whereas BLP-tolerised cells displayed a strong inhibition in
Figure 2. miR-146a is involved in BLP-induced self-tolerance. (A and B) Human THP-1 cells were pre-incubated with either culture medium
(naive) or 100 ng/ml BLP (BLP-tolerised) for 18 h, and further stimulated with 1,000 ng/ml BLP for 6 h (A) or 24 h (B). (C and D) THP-1 cells were
transfected with 40 nM of either miR-146a mimic or miRNA negative control (C) and then stimulated with 1,000 ng/ml BLP for 6 h (D). TNF-
a concentrations in the culture supernatants were assessed by ELISA and miR-146a levels in THP-1 cells were detected by real-time PCR. Data are
presented as mean 6 SE of three independent experiments and each experiment was conducted in triplicate. *p,0.05, **p,0.01 compared with
naive cells or miRNA negative control-transfected cells.
doi:10.1371/journal.pone.0062232.g002
miR-146a and BLP Tolerance
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both IRAK-1 expression and IkBa phosphorylation in response to
S. typhimurium stimulation (Figure 4A-D). Transfection of miR146a
mimic in naı¨ve THP-1 cells caused a substantial decrease in
IRAK-1 expression (Figure 4A and 4C) and attenuated S.
typhimurium-induced phosphorylation of IkBa (Figure 4B and
4D), similar to those seen in BLP-tolerised cells.
Discussion
In the present study, we showed that BLP induced TNF-
a production in THP-1 cells in a dose-dependent manner and that
BLP also upregulated miR-146a expression in THP-1 cells as
shown in prior studies [15,26]. We have additionally confirmed
that miR-146a upregulation increases over time with ongoing BLP
exposure [26], and the addition of our 12-h timepoint showed that
this occurs in a dose-dependent fashion. Our data have newly
demonstrateed that BLP-induced miR-146a expression is dose-
dependent and that the time-dependent rise in miR-146a levels
correlates with the simultaneous decrease in TNF-a levels seen
over time. This suggests that miR-146a may play a direct or
indirect role in suppression of TNF-a expression, as has since been
shown in studies with LPS [23,29]. Our data also suggest that
miR-146a may play a similar role in BLP-induced tolerance. We
found that miR-146a was further upregulated in BLP-tolerised
cells in response to BLP re-stimulation. Transfection of miR-146a
mimics in naive cells led to reduced TNF-a release in response to
BLP stimulation, a phenomenon which has previously been shown
to also occur in response to LPS stimulation [23]. These results
Figure 3. miR-146a participates in BLP-induced cross-tolerance to gram-negative bacteria. (A and B) Human THP-1 cells were pre-
incubated with either culture medium (naive) or 100 ng/ml BLP (BLP-tolerised) for 18 h, and further stimulated with 16106 CFU/ml heat-killed S.
typhimurium (S. typhi) or 16107 CFU/ml heat-killed S. aureus for 6 h. (C and D) THP-1 cells were pre-incubated with various doses of BLP for 18 h, and
further stimulated with 16106 CFU/ml S. typhimurium for 6 h. (E and F) THP-1 cells were transfected with 40 nM of either miR-146a mimic or miRNA
negative control and then stimulated with 16106 CFU/ml S. typhimurium (E) or 16107 CFU/ml S. aureus (F) for 6 h. TNF-a concentrations in the
culture supernatants were assessed by ELISA, and miR-146a levels in THP-1 cells were detected by real-time PCR and expressed as fold expression.
Data are presented as mean6 SE of three independent experiments, and each experiment was conducted in triplicate. *p,0.05, **p,0.01 compared
with naive cells or miRNA negative control-transfected cells.
doi:10.1371/journal.pone.0062232.g003
miR-146a and BLP Tolerance
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and ours suggest miR-146a may be instrumental in the de-
velopment of bacterial components-induced tolerance.
Studies to determine the mechanism of action of miR-146a
have shown that miR-146a targets and inhibits IRAK-1 and
TRAF6 [15,23], suggesting that miR-146a may play a negative
feedback role on the MyD88-dependent pathway. El Gazzar et al.
[29] demonstrated two further roles for miR-146a in development
of endotoxin tolerance. Firstly miR-146a was shown to be involved
in binding of the transcriptional repressor RelB to the TNF-
a promoter region; miR-146a also regulates translational re-
pression of TNF-a by preventing interaction of RNA-binding
protein effectors argonaute-1 and RNA binding motif 4. However,
the degree of tolerance induced by miR-146a overexpression alone
did not reach the TNF-a suppression levels seen in BLP tolerance
– in our study TNF-a levels were reduced from 4,731 pg/ml to
1,487 pg/ml in the miR-146a mimic-transfected group compared
to reduction from 3,937 pg/ml to 232 pg/ml in the BLP-tolerised
group. The only other study which has looked at miRNA in
tolerance via the TLR2 signaling pathway also found that TNF-
a suppression was not seen to the same extent in miR-146a mimic-
transfected cells and PGN-tolerised cells [26]. Whilst miR-146a
mimic transfection induces tolerance effects it does not completely
reduce TNF-a expression, suggesting that miR-146a is not the
solely responsible mediator for tolerance in these cells. Other
miRNAs which are known to target TNF-a expression in LPS-
tolerised cells are miR-221, miR-579 and miR-125b [30].
However, mimic transfection of miR-221, miR-579 and miR-
125b only restores TNF-a levels to approximately 80% that of
non-tolerised cells [30]. As all four miRNAs target TNF-a, there is
likely a mutual requirement for their expression for the full effects
of tolerance to be seen.
We assessed miR-146a levels in BLP-tolerised cells cross-
stimulated with both gram-negative and gram-positive bacteria
and found that miR-146a expression was further increased in
BLP-tolerised cells following a subsequent bacterial stimulus,
reaching a significant difference in the case of stimulation with
gram-negative S. typhimurium. Furthermore, we have shown that
this effect is dependent on the tolerising dose of BLP used. We
subsequently demonstrated that transfection of miR-146a mimic
substantially attenuated S. typhimurium-stimulated TNF-a produc-
tion, indicating that overexpression of miR-146a may account, at
least in part, for the observed cross-tolerance effect.
As discussed previously, miR-146a targets and suppresses
IRAK-1 and TRAF6 [15,26]. We further demonstrated that
miR-146a overexpression suppressed baseline and S. typhimurium-
stimulated IRAK-1 expression to that of BLP-tolerised cells and
that miR-146a mimic transfection resulted in a strong inhibition in
S. typhimurium-induced activation of IkBa similar to that seen in
BLP-tolerised cells. Jurkin et al. [31] have shown that miR-146a
overexpression in PGN-stimulated monocytic cells results in dose-
dependently diminished downstream signaling with lower levels of
IkBa phosphorylation and degradation, indicating impaired NF-
kB signaling. Phosphorylated p38 levels are also reduced but
phosphorylated ERK and TLR2 expression levels are unaffected
[31]. miR-146a mimic-transduced cells show consistently lower
percentages of nuclear p65-positive cells [31]. Our results
Figure 4. Overexpression of miRNA-146a attenuates IRAK-1 expression and IkBa phosphorylation. Human THP-1 cells were pre-
incubated with either culture medium (naive) or 100 ng/ml BLP (BLP-tolerised) for 18 h, or transfected with 40 nM miR-146a mimic. Naive (N), BLP-
tolerised (T) and miR-146a mimic-transfected (M) cells were further stimulated with 16106 CFU/ml heat-killed S. typhimurium for the indicated time
periods. Cytoplasmic proteins were extracted and subjected to immunoblotting for detection of expression of IRAK-1 (A) and phosphotylated IkBa
(p-IkBa) (B). The intensity of each band corresponding with the signal of either IRAK-1 (C) or p-IkBa (D) was corrected by its corresponding b-actin
band after scanning and expressed as the percentage of the intensity detected in naive cells. All data are presented as mean 6 SE of three separate
experiments. *p,0.05 compared with naive cells.
doi:10.1371/journal.pone.0062232.g004
miR-146a and BLP Tolerance
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combined with those from Jurkin et al. [31] demonstrate that
miR-146a overexpression downregulates IRAK-1 expression with
concomitant reduction in NF-kB signaling. Induction of miR-146a
is known to be NF-kB dependent [15] and thus is a pivotal
component of a negative feedback loop invoked by TLR signaling.
The clinical significance of tolerance remains an area of debate.
Strong suppression of proinflammatory signals due to high
tolerance levels may create a degree of host ‘‘immunosuppression’’
potentially leaving them susceptible to further microbial infection.
Complete LPS hyporesponsiveness may increase susceptibility to
overwhelming infection [32] and endotoxin tolerance states are
associated with the increased mortality due to secondary infection
[9,10]. On the other hand, an appropriate tolerance response can
protect the host from an overwhelming inflammatory response
which may itself prove fatal. Induction of tolerance can render
a patient less susceptible to the pathological effects of circulating
endotoxin and thereby reduce the exaggerated immune response
to microbial sepsis which may have deleterious consequences [32].
The effects of tolerance both in vitro and in vivo have been shown to
be dose-dependent and recent studies further confirm similar dose-
dependent expression of ‘‘tolerising’’ miRNAs in vitro [23,33]. The
degree of miRNA expression induced or suppressed appears to be
directly proportional to the dose of the initial stimulus and may
therefore be partially responsible for the clinical tolerance
phenotype which results. The dose-response relationship may be
the key to the clinical implications of tolerance [34].
Taken together, our results demonstrate that miR-146a is
upregulated by and negatively regulates the TLR2 signaling
pathway. These results suggest that miR-146a plays a role in BLP
self-tolerance and cross-tolerance to gram-negative bacteria. miR-
146a may represent a future target for exogenous modulation of
tolerance in the host innate immune response to microbial
infection.
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